NEW YORK, N.Y. – Pfizer Inc. (NYSE:PFE) today announced that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted to recommend Pfizer’s TicoVacTM (tick-borne encephalitis… Read More
The FDA published a long-awaited proposed rule on Quality System Regulation on Tuesday. It’s part of an effort that has been underway since 2018 to harmonize U.S. good manufacturing practices with international… Read More
“Feedback from Canadian biotech companies on the contribution of young workers has been overwhelmingly positive. The Catalyst Award is our way to highlight new hires, showcase their achievements and tell… Read More
BIOTECanada is pleased to announce the launch of Bio+ech Connec+, a unique forum for early-stage Canadian biotech companies to connect directly with the business development and investment leaders of multinational pharma/biotech companies…. Read More
Approval based on results from Phase 3 CROWN trial, showing LORVIQUA reduced risk of disease progression or death by 72% in newly diagnosed individuals compared to XALKORI® (crizotinib) NEW YORK… Read More
